Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
GLP-1 medications such as Ozempic and Wegovy have had a transformative effect for those struggling with weight loss. Many ...
The Growing Market for Weight Loss Treatments: Innovation, Patents, and the Future of GLP-1 Agonists
In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...
In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease ... cancer and dementia, a sweeping new study shows.The research also points to important and perhaps ...
Oprah Winfrey says taking a GLP-1 drug such as Ozempic and Wegovy has changed her entire perspective on “thin people.” A Type 2 diabetes medication that can also aid in weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback